Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff.
Poor distal runoff and hyperlipidemia are factors affecting the fate of an implanted graft. In the present study, combined effects of poor distal runoff and hyperlipidemia on intimal hyperplasia (IH) of the vein graft were examined in a newly developed poor distal runoff model in rabbits. A poor distal runoff model was prepared in the right hindlimb of 30 rabbits. These animals were divided into two groups, depending on the diet provided; normolipidemic diet group (Group NL, n = 14) and hyperlipidemic 1% cholesterol diet group (Group HL, n = 16). Four weeks after preparing the poor runoff model, the femoral vein was implanted into the ipsilateral femoral artery. At 2, 4 and 6 weeks, the grafts were harvested. IH of the graft was measured and macrophages in the IH were examined immunohistochemically. Intimal cell proliferation was also determined by bromodeoxyuridine (BrdU) incorporation. IH of the vein graft was significantly accelerated in cases of poor distal runoff and hyperlipidemia. There were no macrophages in the IH in the NL group. In the HL group, macrophages infiltrated the outer layer of IH, sometimes just above the internal elastic lamina, and increased with time. In the poor distal runoff limbs at 6 weeks, macrophages also appeared in the subendothelial layer but were absent in that layer in the controls. Intimal cell proliferation expressed as the BrdU labeling index (LI) was maximum at 2 weeks. In the HL group, BrdU LI of IH in the poor distal runoff limb was higher than in the control at 2 and 4 weeks. Throughout the experiments, BrdU LIs in the HL group were significantly higher than in the NL. Hyperlipidemia accelerates intimal cell proliferation to a greater extent, then does IH. In cases of a poor distal runoff, the enhancement of cell proliferation by hyperlipidemia is augmented. These responses, in the presence of a hyperlipidemia, may be closely related to the migration of macrophages.
Itoh
H
H
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Komori
K
K
Funahashi
S
S
Okadome
K
K
Sugimachi
K
K
D000818:Animals; D001973:Bromodeoxyuridine; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D005268:Femoral Vein / Q000637:transplantation*; D006614:Hindlimb / Q000098:blood supply; D006949:Hyperlipidemias / Q000473:pathology*; D006965:Hyperplasia; D007150:Immunohistochemistry; D008264:Macrophages / Q000473:pathology; D008297:Male; D011817:Rabbits; D012039:Regional Blood Flow; D017539:Tunica Intima / Q000473:pathology*
D002791:Cholesterol, Dietary; D001973:Bromodeoxyuridine